Missed Opportunities for Prevention of Mother-to-Child Transmission of HIV (PMTCT) in Ibadan, Southwest Nigeria
Babatunde O. Ogunbosi1,2*, Regina E. Oladokun1,2, Olutosin Awolude3,4, Biobele J. Brown1, Olubukola A. Adeshina3,4, Modupe Kuti5, Babafemi Taiwo6,7, Baiba Berzins6,7, Demetrious N. Kyriacou7,8, Ellen G. Chadwick9, Kikelomo Osinusi1,2, Isaac F. Adewole3,4, Robert L. Murphy6,7
1Department of Paediatrics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
2Department of Paediatrics, University College Hospital, Ibadan, Nigeria.
3Department of Obstetrics and Gynecology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
4Department of Obstetrics and Gynecology, University College Hospital, Ibadan, Nigeria.
5Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
6Department of Internal Medicine, Feinberg School of Medicine, Northwestern University, Chicago, USA.
7Center for Global Health, Institute for Public Health and Medicine, Feinberg School of Medicine, Northwestern University, Chicago, USA.
8Department of Emergency Medicine, Feinberg School of Medicine, Northwestern University, Chicago, USA.
9Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, USA.
DOI: 10.4236/wja.2014.43042   PDF    HTML     3,995 Downloads   5,895 Views   Citations

Abstract

Background: Nigeria has the largest paediatric HIV-infected population in the world. Missed opportunities for prevention of mother-to-child transmission of HIV (PMTCT) compromise efforts at eliminating new pediatric HIV infections. Methods: Six hundred children, aged < 15 years, presenting to the pediatric units of the University College Hospital (UCH), Ibadan Southwest Nigeria between June to December 2007 were studied. The demographics, HIV status and socioeconomic status of mothers and their children were studied. A 4-step hierarchy was used to assess the missed opportunities for PMTCT. Step 1: utilization of a health facility for antenatal care and delivery; Step 2: maternal HIV status determination during pregnancy; Step 3: provision of antiretroviral medication to HIV-infected mother and baby; and Step 4: avoidance of mixed feeding in HIV-exposed children. The rates of missed opportunities for PMTCT services at different steps in the PMTCT cascade, perinatal transmission rates, and associated factors were reported. Results: There were 599 mothers and 600 children (one set of twins), 60 (10%) were HIV infected and 56 (93.3%) of these were adjudged perinatally infected. Of 78 HIV-infected women, 7 (9.0%) accessed all interventions in the PMTCT cascade and 71 (91.0%) had missed opportunities for PMTCT. Missed opportunities for PMTCT occurred 42.9% in cascade Step 1, 64.2% in Step 2, 52.6% in step 3 and 73.7% in Step 4. All mother-baby pairs who accessed complete PMTCT interventions received care at a teaching hospital. Among infants with perinatal HIV infection, 53 (94.6%) were born to mothers who had missed opportunities for PMTCT. Most women with missed opportunities attended antenatal care outside the teaching hospital setting and belonged to low socioeconomic status. Conclusion: It is imperative to expand PMTCT access to women who receive antenatal care outside the teaching hospitals and to those of low socioeconomic status.

Share and Cite:

Ogunbosi, B. , Oladokun, R. , Awolude, O. , Brown, B. , Adeshina, O. , Kuti, M. , Taiwo, B. , Berzins, B. , Kyriacou, D. , Chadwick, E. , Osinusi, K. , Adewole, I. and Murphy, R. (2014) Missed Opportunities for Prevention of Mother-to-Child Transmission of HIV (PMTCT) in Ibadan, Southwest Nigeria. World Journal of AIDS, 4, 356-364. doi: 10.4236/wja.2014.43042.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] UNAIDS (2011) Global HIV/AIDS Response—Epidemic Update and Health Sector Progress towards Universal Access—Progress Report 2011. UNAIDS, Geneva.
[2] UNAIDS (2011) Global Plan towards the Elimination of New HIV Infections among Children by 2015 and Keeping Their Mothers Alive 2011-2015. UNAIDS, Geneva.
[3] De Cock, K.M., Fowler, M.G., Mercier, E., de Vincenzi, I., Saba, J., Hoff, E., Alnwick, D.J., Rogers, M. and Shaffer, N. (2000) Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries: Translating Research into Policy and Practice. JAMA, 283, 1175-1182.
http://dx.doi.org/10.1001/jama.283.9.1175
[4] Wiktor, S.Z., Ekpini, E. and Nduati, R.W. (1997) Prevention of Mother-to-Child Transmission of HIV-1 in Africa. AIDS, 11, S79-S87.
[5] Connor, E.M., Sperling, R.S., Gelber, R., Kiselev, P., Scott, G., O’Sullivan, M.J., Van Dyke, R., Bey, M., Shearer, W., Jacobson, R.L., et al. (1994) Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. The New England Journal of Medicine, 331, 1173-1180.
http://dx.doi.org/10.1056/NEJM199411033311801
[6] Connor, E.M. and Mofenson, L.M. (1995) Zidovudine for the Reduction of Perinatal Human Immunodeficiency Virus Transmission: Pediatric AIDS Clinical Trials Group Protocol 076—Results and Treatment Recommendations. The Pediatric Infectious Disease Journal, 14, 536-541.
http://dx.doi.org/10.1097/00006454-199506000-00012
[7] Brocklehurst, P. and Volmink, J. (2002) Antiretrovirals for Reducing the Risk of Mother-to-Child Transmission of HIV Infection. The Cochrane Database of Systematic Reviews 2002, CD003510.
[8] Mandelbrot, L., Landreau-Mascaro, A., Rekacewicz, C., Berrebi, A., Benifla, J.L., Burgard, M., Lachassine, E., Barret, B., Chaix, M.L., Bongain, A., et al. (2001) Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1. JAMA: The Journal of the American Medical Association, 285, 2083-2093. http://dx.doi.org/10.1001/jama.285.16.2083
[9] Brocklehurst, P. and Volmink, J. (2002) Antiretrovirals for Reducing the Risk of Mother-to-Child Transmission of HIV Infection. The Cochrane Database of Systematic Reviews 2002, CD003510.
[10] The European Mode of Delivery Collaboration (1999) Elective Caesarean-Section versus Vaginal Delivery in Prevention of Vertical HIV-1 Transmission: A Randomised Clinical Trial. Lancet, 353, 1035-1039. http://dx.doi.org/10.1016/S0140-6736(98)08084-2
[11] Brocklehurst, P. (2002) Interventions for Reducing the Risk of Mother-to-Child Transmission of HIV Infection. The Cochrane Database of Systematic Reviews, Published Online.
[12] Mofenson, L.M. (2010) Prevention in Neglected Subpopulations: Prevention of Mother-to-Child Transmission of HIV Infection. Clinical Infectious Diseases, 50, S130-S148.
http://dx.doi.org/10.1086/651484
[13] UNAIDS (2010) Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. UNAIDS, Geneva.
[14] Peters, V., Liu, K.L., Dominguez, K., Frederick, T., Melville, S., Hsu, H.W., Ortiz, I., Rakusan, T., Gill, B. and Thomas, P. (2003) Missed Opportunities for Perinatal HIV Prevention among HIV-Exposed Infants Born 1996-2000, Pediatric Spectrum of HIV Disease Cohort. Pediatrics, 111, 1186-1191.
[15] Turchi, M.D., Duarte, S. and Martelli, C.M. (2007) Mother-to-Child Transmission of HIV: Risk Factors and Missed Opportunities for Prevention among Pregnant Women Attending Health Services in Goiania, Goiás State, Brazil. Cadernos de Saúde Pública, 23, S390-S401.
http://dx.doi.org/10.1590/S0102-311X2007001500007
[16] Rodrigues, C.S., Guimaraes, M.D. and César, C.C. (2008) Missed Opportunities for Congenital Syphilis and HIV Perinatal Transmission Prevention. Revista de Saúde Pública, 42, 851-858.
http://dx.doi.org/10.1590/S0034-89102008000500010
[17] Bailey, H., Townsend, C., Cortina-Borja, M. and Thorne, C. (2011) Insufficient Antiretroviral Therapy in Pregnancy: Missed Opportunities for Prevention of Mother-to-Child Transmission of HIV in Europe. Antiviral Therapy, 16, 895-903. http://dx.doi.org/10.3851/IMP1849
[18] Ogunbosi, B.O., Oladokun, R.E., Brown, B.J. and Osinusi, K.I. (2011) Prevalence and Clinical Pattern of Paediatric HIV Infection at the University College Hospital, Ibadan, Nigeria: A Prospective Cross-Sectional Study. Italian Journal of Pediatrics, 37, 29.
[19] WHO (2010) Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach. 2010 Version. WHO, Geneva.
[20] Reducing the Odds (1999) Preventing Perinatal Transmission of HIV in the US, US Institute of Medicine Report. Institute of Medicine, Washington DC.
[21] SPSS 11.0 for Windows (2001) SPSS Inc., Chicago.
[22] NPC (2009) Nigeria Demographic and Health Survey 2008. National Population Commission, Abuja.
[23] Rai, R.K., Singh, P.K. and Singh, L. (2012) Utilization of Maternal Health Care Services among Married Adolescent Women: Insights from the Nigeria Demographic and Health Survey, 2008. Women’s Health Issues, 22, e407-e414. http://dx.doi.org/10.1016/j.whi.2012.05.001
[24] Stringer, E.M., Ekouevi, D.K., Coetzee, D., Tih, P.M., Creek, T.L., Stinson, K., Giganti, M.J., Welty, T.K., Chintu, N., Chi, B.H., et al. (2010) Coverage of Nevirapine-Based Services to Prevent Mother-to-Child HIV Transmission in 4 African Countries. JAMA, 304, 293-302. http://dx.doi.org/10.1001/jama.2010.990
[25] Oladokun, R.E., Awolude, O., Brown, B.J., Adesina, O., Oladokun, A., Roberts, A., Odaibo, G., Osinusi, K., Olaleye, D., Adewole, I.F., et al. (2010) Service Uptake and Performance of the Prevention of Mother-to-Child Transmission (PMTCT) Programme in Ibadan, Nigeria. African Journal of Medicine and Medical Sciences, 39, 81-87.
[26] Wade, N.A., Birkhead, G.S., Warren, B.L., Charbonneau, T.T., French, P.T., Wang, L., Baum, J.B., Tesoriero, J.M. and Savicki, R. (1998) Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus. The New England Journal of Medicine, 339, 1409-1414. http://dx.doi.org/10.1056/NEJM199811123392001
[27] UNAIDS (2009) Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2009.
[28] WHO (2006) Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Towards Universal Access: Recommendations for a Public Health Approach. 2006 Version. WHO, Geneva.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.